Search

everythinglearnresearchcommunity

for

Search:↓

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

No treatment fully stops excessive hair growth in women, but various methods can help manage it effectively.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

Adults can develop late-onset loose anagen syndrome, which may often be misdiagnosed.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

People with acne have more CD4+ immune cells in their skin than healthy people.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Lower testosterone levels in men may be linked to a higher risk of severe coronary artery disease.

Alopecia linked to higher anxiety and personality disorders.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Patients need long-term care after bariatric surgery to manage potential nutritional and metabolic issues.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Oestrogens are key for bone growth during puberty in both boys and girls.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Finasteride improves hair loss in women with hyperandrogenism.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Iron deficiency common in women, not always linked to hair loss; more research needed.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.